Trial Profile
Prospective Assessment of Relapse Characteristics of Plasmodium Ovale and Antimalarial Treatment Efficacy of Artemether-lumefantrine for Mixed Species and Non-falciparum Malaria in Gabon
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Feb 2017
Price :
$35
*
At a glance
- Drugs Artemether/lumefantrine (Primary)
- Indications Falciparum malaria; Malaria
- Focus Therapeutic Use
- Acronyms REPLAMO
- 24 Jan 2017 Status changed from recruiting to completed.
- 21 Aug 2015 New trial record